Furiex Pharmaceuticals Company Profile

10:11 EDT 22nd September 2014 | BioPortfolio


News Articles [55 Associated News Articles listed on BioPortfolio]

INVESTOR ALERT - FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the Sale of Furiex Pharmaceuticals, Inc. -- FURX

NEW YORK, April 30, 2014 /PRNewswire/ --The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Furiex Pharmaceuticals, Inc. (NasdaqGS: FURX) ("Furiex"...

Forest Labs scoops up Furiex Pharma for $1.1 billion

Forest Laboratories and Furiex Pharmaceuticals has entered into a m&a definitive agreement to acquire Furiex for $95 per share, or approximately $1.1 billion in cash. Also up to $30 per share (app...

Forest Labs to buy Furiex in deal worth $1.5B

Forest Laboratories says it will spend as much as $1.5 billion to buy Furiex Pharmaceuticals Inc. in a deal that could give the drugmaker one of the broadest product lines for gastrointestinal treatme...

Harwood Feffer LLP Announces Investigation of Furiex Pharmaceuticals, Inc.

NEW YORK, April 28, 2014 /PRNewswire/ --Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Furiex Pharmaceuticals, Inc. ("Furiex" or the "Compan...

Forest gaining 'relevant' GI position with Furiex buy

In fact, Forest president and CEO Brent Saunders consulted closely with Actavis chairman and CEO Paul Bisaro during the final negotiations with Morrisville, North Carolina-based Furiex. But Forest's i...

Actavis Acquires Furiex Pharmaceuticals

Actavis plc announced that its subsidiary Forest Laboratories LLC has successfully completed its acquisition of Furiex Pharmaceuticals Inc.Read more

Forest Labs Bids $1.5 Billion To Acquire Furiex

Forest Laboratories announced that it will spend as much as $1.5 billion in its latest acquisition bid to buy Furiex Pharmaceuticals. Acquiring Furiex would give Forest Labs one of the broadest produc...

Morgan & Morgan Announces the Investigation of Furiex Pharmaceuticals, Inc. FURX

NEW YORK, April 28, 2014 /PRNewswire/ --Morgan & Morgan announces that it is investigating the Board of Directors of Furiex Pharmaceuticals, Inc. ("Furiex" or the "Company") (NASDAQ: FURX) concern...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Furiex Pharmaceuticals, Inc.

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by adva...

Furiex Pharmaceuticals

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

More Information about "Furiex Pharmaceuticals" on BioPortfolio

We have published hundreds of Furiex Pharmaceuticals news stories on BioPortfolio along with dozens of Furiex Pharmaceuticals Clinical Trials and PubMed Articles about Furiex Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Furiex Pharmaceuticals Companies in our database. You can also find out about relevant Furiex Pharmaceuticals Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record